BioCompounding

Subscribe

Latest

Medtronic Deep Dive - The Awakening of a Sleeping Giant: Medtronic’s Strategic Pivot to Innovation-Driven Growth

Medtronic Deep Dive - The Awakening of a Sleeping Giant: Medtronic’s Strategic Pivot to Innovation-Driven Growth

I. The Premise: Assessing the Sleeping Giant 1.1. Introduction: Validating the "Awakening" Thesis The term "Sleeping Giant" has historically applied to Medtronic plc (NYSE: MDT) due to its immense market capitalization, global footprint, and foundational role in health technology, often contrasted with periods of slower

West Pharmaceutical 2.0: Shifting from being just an elastomer supplier to providing integrated solutions

West Pharmaceutical 2.0: Shifting from being just an elastomer supplier to providing integrated solutions

Align Technology (ALGN): Modernizing dentistry with 3D printing and digitalization

Align Technology (ALGN): Modernizing dentistry with 3D printing and digitalization

West Pharmaceuticals (WST) - enabling pharmaceutical companies to get their products to their customers

West Pharmaceuticals (WST) - enabling pharmaceutical companies to get their products to their customers

An Overview of ADC Therapeutic's in Oncology

An Overview of ADC Therapeutic's in Oncology

From Blueprint to Therapy: The Evolution and Challenges of Nucleic Acid Interventions

From Blueprint to Therapy: The Evolution and Challenges of Nucleic Acid Interventions

Intuitive Surgical

Crucial Metrics to Monitor for Intuitive Surgical and a Valuation Analysis

Technologies in 5 mins

An Overview of ADC Therapeutic's in Oncology

An Overview of ADC Therapeutic's in Oncology

Part 1: Exploring ADC functionality and an overview of FDA-approved oncology treatments As part of the expansion from our “Exploring Drug Modalities: Small Molecules, Biologics, RNA, Cell & Gene Therapy” article, we have previously described how Chimeric Antigen Receptor (CAR)-T cell therapies are used to treat various types of

From Blueprint to Therapy: The Evolution and Challenges of Nucleic Acid Interventions

From Blueprint to Therapy: The Evolution and Challenges of Nucleic Acid Interventions

An Overview of CAR-T Cell Therapy And a New Manufacturing Method

An Overview of CAR-T Cell Therapy And a New Manufacturing Method

The race to sequence the world - A look at Next Generation Sequencing (NGS)

The race to sequence the world - A look at Next Generation Sequencing (NGS)

All you need to know about Gene Therapy

All you need to know about Gene Therapy

Exploring Drug Modalities: Small Molecules, Biologics, RNA, Cell & Gene Therapy

Exploring Drug Modalities: Small Molecules, Biologics, RNA, Cell & Gene Therapy

Can Precision Fermentation together with Synthetic Biology Help to Secure Our Food Systems?

Can Precision Fermentation together with Synthetic Biology Help to Secure Our Food Systems?

Deep Dives

Medtronic Deep Dive - The Awakening of a Sleeping Giant: Medtronic’s Strategic Pivot to Innovation-Driven Growth

Medtronic Deep Dive - The Awakening of a Sleeping Giant: Medtronic’s Strategic Pivot to Innovation-Driven Growth

I. The Premise: Assessing the Sleeping Giant 1.1. Introduction: Validating the "Awakening" Thesis The term "Sleeping Giant" has historically applied to Medtronic plc (NYSE: MDT) due to its immense market capitalization, global footprint, and foundational role in health technology, often contrasted with periods of slower

West Pharmaceutical 2.0: Shifting from being just an elastomer supplier to providing integrated solutions

West Pharmaceutical 2.0: Shifting from being just an elastomer supplier to providing integrated solutions

Align Technology (ALGN): Modernizing dentistry with 3D printing and digitalization

Align Technology (ALGN): Modernizing dentistry with 3D printing and digitalization

West Pharmaceuticals (WST) - enabling pharmaceutical companies to get their products to their customers

West Pharmaceuticals (WST) - enabling pharmaceutical companies to get their products to their customers

Intuitive Surgical

Crucial Metrics to Monitor for Intuitive Surgical and a Valuation Analysis

Ascendis Pharma (ASND): Redefining Drug Delivery with TransCon

Halozyme Therapeutics (HALO): Bets on Licensing Model to Drive Growth

Halozyme Therapeutics (HALO): Bets on Licensing Model to Drive Growth

News

Are RSV vaccines going to be the next blockbuster vaccine to be developed?

Are RSV vaccines going to be the next blockbuster vaccine to be developed?

The below graph shows that the rate of RSV-associated hospitalizations has increased significantly after the COVID pandemic (2020-2021 season). In the 2022-2023 season, the current estimate for RSV-associated hospitalization stood at 18 per 100k people in the US. However, this is just the start of the RSV season, and the

3 Top Biotech News Of The Week (22 Oct 2022) - Oculis, LLY, AKUS, JAZZ, ZYME

3 Top Biotech News Of The Week (22 Oct 2022) - Oculis, LLY, AKUS, JAZZ, ZYME

A look at Nimbus & Eli Lilly's AMPK Collaboration, Regeneron and Sanofi's Dupixent EOE approval and Merck's Sotatercept for PAH

A look at Nimbus & Eli Lilly's AMPK Collaboration, Regeneron and Sanofi's Dupixent EOE approval and Merck's Sotatercept for PAH

3 Top Biotech News Of The Week (8 October 22) - BMS, AUTL, DNA, Svante Pääbo discovery

3 Top Biotech News Of The Week (8 October 22) - BMS, AUTL, DNA, Svante Pääbo discovery

3 Top Biotech News Of The Week (1 October 22)

3 Top Biotech News Of The Week (1 October 22)

3 Top Biotech News Of The Week (10 September 22)

3 Top Biotech News Of The Week (10 September 22)

3 Top Biotech News Of The Week (3 September 22)

3 Top Biotech News Of The Week (3 September 22)

Market Overview

More

GLP-1 Drugs: Not a Miracle Cure for Weight Loss

5 Blockbuster Drugs Which Can Be Spun Out as a Company

Earnings Update for NVO, LLY & REGN

What You Need to Know About Growth Investing & Two Potential Metrics to Use

8 Gene Editing/CRISPR Companies to Consider For Your Portfolio

Sample Deep Dives

More

Intuitive Surgical (ISRG) Deep Dive

Danaher Corporation (DHR) Valuation Exercise

Novo Nordisk (NVO) Deep Dive

Thermo Fisher Scientific (TMO) Deep Dive

Why Regeneron Pharmaceuticals Inc (NASDAQ: REGN) is a biotech force to be reckoned with